Kristen Hallam on Muck Rack

Kristen Hallam Verified

Covers:  science, health policy, biotechnology, mergers & acquisitions, health, pharmaceutics
Doesn't Cover: clinical trial initiation, new product launches

@BloombergNews health editor in London. @NorthwesternU alum, @AHCJ member. Email: khallam@bloomberg.net. RTs & links not endorsements.

AstraZeneca CEO Raises Bar for Deals After Acquisitions Spree

bloomberg.com — AstraZeneca Plc pledged to only pursue acquisitions that immediately add to the drugmaker's bottom line, following a deal spree in the last quarter of 2015. "We have what we need to have," Chief Executive Officer Pascal Soriot told journalists Thursday in London, where the company is based.
Feb 04, 2016

AstraZeneca CEO raises the bar for deals after acquisitions spree bloom.bg/1TG4pVa via @business $AZN pic.twitter.com/Mf4A4C8YDj

Index Ventures Spins Off Biotech Investment Arm Into New Firm

bloomberg.com — Index Ventures, best known for funding startups like Skype and the creator of the Candy Crush Saga online game, is spinning off its biotechnology investments into a new venture-capital firm.

Hugo Boss Gains as Sales Increase Reassures Amid Profit Setback

businessoffashion.com — METZINGEN, Germany - German clothier Hugo Boss AG reassured investors by announcing growth in fourth-quarter sales and profit, sending the shares higher. Revenue rose 10 percent and operating profit 2 percent, the Metzingen-based company said Friday in a statement, easing concern over the impact on business of November's Paris terror attacks and unseasonably mild weather.

Cancer Drug Potential Makes Roche the Darling of Pharma: Chart

bloomberg.com — Roche Holding AG is analysts' favorite big pharmaceutical stock going into JPMorgan Chase & Co.'s annual health-care conference, where industry executives flock to hold court with top investors. The world's biggest maker of cancer drugs, based in Switzerland, won U.S. approval for two new medicines last quarter.
Jan 12, 2016

Cancer Drug Potential Makes Roche the Darling of Pharma: Chart bloom.bg/1TS0GC2 via @business @kristen_hallam

Jan 12, 2016

RT @EvavonSchaper: Cancer Drug Potential Makes Roche the Darling of Pharma: Chart bloom.bg/1TS0GC2 via @business @kristen_hallam

Show 4 more tweets from Brooke Sutherland, Anna Edney and others...

Pharma Deal Frenzy May Continue in 2016, Jefferies Survey Finds

bloomberg.com — The record year for pharmaceutical and biotech deals may spill over into 2016, according to a survey by Jefferies Group LLC. More than three-quarters of participants who answered questions about the industry at last week's Jefferies Global Healthcare Conference in London said purchasing activity will be at least as strong as it was this year, if not more.
Nov 26, 2015

Pharma Deal Frenzy May Continue in 2016, Jefferies Survey Finds bloom.bg/1OrNTnS via @kristen_hallam

Nov 26, 2015

RT @maki_kitamura: Pharma Deal Frenzy May Continue in 2016, Jefferies Survey Finds bloom.bg/1OrNTnS via @kristen_hallam

Euro Leaders Sleepless Summits Seen Prone to Mistakes

bloomberg.com — July 18 (Bloomberg) -- If the leaders of the 17 euro-area countries really want to solve the debt crisis shadowing their currency, they may want to sleep on it. That's not likely to happen. Of Europe's last six summits, three ended no earlier than 4 a.m.
Jul 12, 2015

2015? No. we wrote this in 2012 --Euro Leaders Sleepless Summits Seen Prone to Mistakes bloomberg.com/news/articles/… via @business

Jul 12, 2015

Time to revisit this crucial 2012 research: Euro Leaders Sleepless Summits Seen Prone to Mistakes bloom.bg/16qpTQl via @business

Jul 12, 2015

RT @CraigStirling: Time to revisit this crucial 2012 research: Euro Leaders Sleepless Summits Seen Prone to Mistakes bloom.bg/16qpTQl via @business

Jul 12, 2015

Re-reading from 2012 study: Euro Sleepless Summits may ``impair brain function and lead to misjudgments.'' bloom.bg/16qpTQl #Greece

Jul 12, 2015

Throwback Sunday: Euro Leaders Sleepless Summits Seen Prone to Mistakes bloom.bg/16qpTQl via @business (h/t @stephaniebodoni)

Show 1 more tweet from Zoe Schneeweiss

Texas Hospital Fights Allegations of Lax Ebola Protocols

bloomberg.com — Texas Health Presbyterian Hospital in Dallas, where two health workers were infected with Ebola after treating a patient who later died of the virus, disputed allegations made by a nurses' union about infection controls. "The assertions do not reflect actual facts learned from the medical record and interactions with clinical caregivers," the hospital said today in a statement.

AbbVie Reconsidering Shire Sends Inversion Targets Down

bloomberg.com — AstraZeneca Plc and other health-care companies considered to be tax-friendly takeover targets fell after U.S. pharmaceutical company AbbVie Inc. (ABBV) said it was reconsidering its $51.5 billion bid for Shire Plc. (SHP) AstraZeneca, a London-based drugmaker that spurned a takeover offer from Pfizer Inc. (PFE) this year, dropped 3.5 percent to 42.54 pounds at 9:22 a.m.

Inversion Deal Crackdown Sends AstraZeneca, Shire Down

bloomberg.com — Shares of U.K. health-care companies sought after as takeover targets fell after a top U.S. official disclosed plans to crack down on overseas deals that enable American companies to cut their tax rates. AstraZeneca Plc, the London-based drugmaker that was the target of a failed bid by U.S.

CVS revamp ends tobacco sales early

buffalonews.com — CVS Caremark Corp. halted sales of tobacco products almost a month ahead of schedule, started a smoking-cessation campaign and changed its name to position itself as a health care provider as demand grows in the U.S. market.CVS Health, as the company now calls itself, will forgo $2 billion...
More Articles →
Feb 05, 2016

RT @FierceBiotech: Hit with a storm of protest, LifeSci Advisors apologizes for its J.P. Morgan party. fiercebiotech.com/story/hit-stor… by @JohnCFierce

Feb 05, 2016

Woodford added to Alkermes, Prothena stakes and bought into Theravance: woodfordfunds.com/insight/wpct-j…

Feb 05, 2016

RT @adamfeuerstein: Brit investor Neil Woodford clobbered by biotech bear market. No mention of $NWBO in his January letter woodfordfunds.com/insight/wpct-j…

Feb 05, 2016

RT @EllenBarryNYT: In Indonesia, 60 million women & girls--nearly 1/2 the female populat'n--believed to have undergone genital cutting. htt…

Feb 04, 2016

RT @ArmstrongDrew: Well, that escalated quickly: Valeant, Turing Slammed as Shkreli Calls Congress ‘Imbeciles’ bloom.bg/1TGnlDe

Feb 04, 2016

RT @SashaDamouni: 2 biotech IPOs postponed this morn, according to @Drew_Singer PLX Pharma & Therapure Biopharma Said to Postpone IPOs on …

Feb 04, 2016

AstraZeneca CEO raises the bar for deals after acquisitions spree bloom.bg/1TG4pVa via @business $AZN pic.twitter.com/Mf4A4C8YDj


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.